Differential role of the influenza A virus polymerase PA subunit for vRNA and cRNA promoter binding  by Maier, Helena J. et al.
Available online at www.sciencedirect.com
8) 194–204
www.elsevier.com/locate/yviroVirology 370 (200Differential role of the influenza A virus polymerase PA subunit for vRNA
and cRNA promoter binding
Helena J. Maier, Takahito Kashiwagi, Koyu Hara 1, George G. Brownlee⁎
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK
Received 20 July 2007; returned to author for revision 20 August 2007; accepted 27 August 2007
Available online 1 October 2007Abstract
The RNA polymerase of influenza A virus is a heterotrimeric complex of PB1, PB2 and PA subunits that is required for transcription and
replication of the viral genome. Here, we demonstrate a differential requirement of the PA subunit for binding to the vRNA and cRNA promoters—
specifically, PA is more important for binding to the cRNA than the vRNA promoter. Furthermore, five point mutations were identified in the
L163–I178 region of PA, which resulted in an inhibition of polymerase activity when provided with a cRNA compared to vRNA promoter. Cross-
linking studies suggested that this inhibition was due to a reduction in promoter binding of the mutant polymerases to the cRNA promoter. We
conclude that the L163–I178 region of PA is directly or indirectly involved in cRNA promoter binding and suggest a novel function for PA in
modulating promoter binding.
© 2007 Elsevier Inc. All rights reserved.Keywords: Influenza; RNA polymerase; PA subunit; vRNA cRNA promoter binding; ReplicationIntroduction
InfluenzaAvirus is a single-stranded, negative-senseRNAvirus
with 8 genome segments, belonging to the family Orthomyxovir-
idae (Palese and Shaw, 2007). Each of the genome segments is
bound by a single copy of the virally encoded RNA-dependant
RNA polymerase and multiple copies of the NP protein to form
ribonucleoprotein complexes (RNPs). The genome segments are
transcribed into mRNA and replicated via a cRNA intermediate by
the polymerase complex. Synthesis of mRNA requires a capped
primer derived from host mRNA by “cap-snatching”. In contrast,
replication of the vRNA genome is primer independent (Fodor and
Brownlee, 2002; Neumann et al., 2004; Palese and Shaw, 2007).
The influenza polymerase is a heterotrimeric complex
formed from the PB1, PB2 and PA subunits. The PB1 subunit
contains an SDD motif which is directly involved in RNA chain
elongation (Argos, 1988; Biswas and Nayak, 1994; Poch et al.,⁎ Corresponding author. Fax: +44 01865 275556.
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doi:10.1016/j.virol.2007.08.0291989). The PB2 subunit contains a cap-binding site and is
involved in “cap-snatching” (Blass et al., 1982; Fechter et al.,
2003; Li et al., 2001). The function of the PA subunit is less well
defined.Most reports find that PA is required for both transcription
and replication (Deng et al., 2006a; Fodor et al., 2002, 2003; Hara
et al., 2006; Huang et al., 1990; Lee et al., 2002; Perales and Ortin,
1997; Regan et al., 2006), although some disagree (Honda et al.,
2002; Nakagawa et al., 1995, 1996). Mutagenesis studies have
shown that PA is involved in endonuclease activity (Fodor et al.,
2002; Hara et al., 2006), in addition to PB1 (Li et al., 2001).
Furthermore, PA is involved in elongation by the polymerase
(Fodor et al., 2003) as well as cap-binding and vRNA and cRNA
promoter binding (Hara et al., 2006). A function for PA in
assembly of the virus particle has also been suggested recently
(Regan et al., 2006) and PA is known to have or induce proteolytic
activity, although the significance of this is not fully understood
(Hara et al., 2001; Perales et al., 2000; Rodriguez et al., 2007;
Sanz-Ezquerro et al., 1996; Toyoda et al., 2003).
Significant progress has been made in understanding the
secondary structure of the vRNA and cRNA promoters and they
are currently proposed to form a “corkscrew” structure con-
sisting of conserved sequences at the 5′ and 3′ ends of each
genome segment. Promoter binding sites have been mapped to
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controversial (Gonzalez and Ortin, 1999; Jung and Brownlee,
2006; Li et al., 1998). However, interactions between PB2 and
PA with the vRNA and cRNA promoters have also been ob-
served (Deng et al., 2005; Fodor et al., 1994, 1993; Hara et al.,
2006; Jung and Brownlee, 2006; Pritlove et al., 1995).
A recent report on the mechanism of de novo initiation of
replication has suggested that different strategies are used on the
vRNA and cRNA promoters. Initiation of replication on the
vRNA promoter is at residues 1 and 2. In contrast, initiation on
the cRNA promoter is internal, at positions 4 and 5, followed by
realignment of a pppApG dinucleotide product to positions 1
and 2, where it acts as a primer (Deng et al., 2006b). These
differences in initiation imply that there must be structural
differences in the binding of the polymerase complex to the two
promoters. It follows that point mutants in any of the 3
polymerase subunits might influence binding of the polymerase
to one promoter to a greater extent than to the other promoter.
In this study, we report that the three polymerase subunits are
required to differing extents in binding to vRNA and cRNA
model promoters. Significantly, the PA subunit is more involved
in binding to the cRNA promoter than to the vRNA promoter. To
identify regions of PA that may be involved in this differential
binding, a previous analysis of the region R170–L175 of the PA
subunit (Hara et al., 2006) was expanded by construction of
another 11 alanine scanning mutants from L163–I178. Signif-
icantly, five mutants (D164A, E165A, E166A, T173A and
F176A) showed reduced binding to a model cRNA promoter
whilst there was little or no effect on binding to a model vRNA
promoter. This suggests a new function for PA in modulating the
recognition of the two promoter structures by the polymerase
complex.
Results
Involvement of the three polymerase subunits in binding to the
vRNA and cRNA promoters
Previously it has been shown that all three influenza virus
polymerase subunits can be UV cross-linked to model vRNA or
cRNA promoters (Deng et al., 2005; Fodor et al., 1994, 1993;
Hara et al., 2006; Jung and Brownlee, 2006; Pritlove et al., 1995).
To characterise the requirement of each subunit for cross-linking
to the two promoters, recombinant polymerase containing A/
WSN/33 (WSN) PB1, PB2-TAP and either WSN PA, A/
HongKong/156/97 (HK/156) PA or WSN PA-GFP (WSN-GFP)
were partially purified from 293T cells (see Materials and
methods) to give polymerase preparations with different banding
patterns of the PA subunit on 7.5%SDS–PAGE (Fig. 1A).Despite
minimal difference in molecular weight between WSN PA and
HK/156 PA, the PA from HK/156 migrated faster (compare lanes
2 and 3). This is possibly due to differences in net charge of PA at
neutral pH (−18.5 and −20.6 forWSN andHK/156, respectively)
(Bishop et al., 1982). TheWSN PA-GFP subunit migrates slower
due to the presence of the GFP tag (lane 4).
Preliminary, qualitative experiments were initially carried out
using these polymerases (Fig. 1A, lanes 2–4) to identify therelative contribution of PB1, PB2 and PA to promoter binding.
Polymerases were UV cross-linked to [32P]-labelled vRNA or
cRNA model promoter followed by immunoprecipitation with
antibodies specific for PB1, PB2 or PA (see Materials and
methods and Fig. 1B). It is notable that, for polymerase con-
taining WSN PA (top panel), the PB2-TAP and PA subunits co-
migrated (compare lanes 3 with 4 and 8 with 9). For polymerase
containing HK/156 PA (middle panel), the PB2-TAP and PA
subunits also co-migrated, although the PA subunit appeared to
migrate slightly faster (compare lanes 3 with 4 and 8 with 9). For
polymerase containing PA-GFP (bottom panel), all three
polymerase subunits migrated at different positions (compare
lanes 2–4 and 7–9). As described previously, the presence of a
C-terminal GFP and TAP tags on the PA or PB2 subunit had no
affect on polymerase activity (Deng et al., 2005; Fodor and
Smith, 2004; Hara et al., 2006). Furthermore, GFP alone did not
cross-link to either the vRNA or the cRNA promoter (data not
shown). Overall, Fig. 1B shows that for all three recombinant
polymerases, the contribution of PA, relative to either PB1 or
PB2, to promoter binding appeared qualitatively greater to the
cRNA than to the vRNA promoter (compare lanes 9 with 7 and
8, and 4 with 2 and 3 in each panel). Conversely, the contribution
of PB1, relative to either PB2 or PA, to promoter binding
appeared greater to the vRNA than to the cRNA promoter
(compare lanes 2 with 3 and 4, and 7 with 8 and 9 in each panel).
Further evidence that PA is more involved in cRNA than
vRNA promoter binding is shown in Fig. 1C, where polymerase
cross-linked to vRNA and cRNA was analysed without
immunoprecipitation. The banding pattern for polymerase
containing WSN PA and HK/156 PA cross-linking to vRNA
appeared similar (compare lanes 2 and 3). However, the banding
pattern for cross-linking to the cRNA promoter was altered,
with a broadening of the lower band in the case of polymerase
containing HK/156 PA (compare lanes 7 and 8). As shown in
Fig. 1A (above), HK/156 PA migrated slightly faster than WSN
PA. Furthermore, immunoprecipitation of polymerase contain-
ing HK/156 PA cross-linked to the vRNA and cRNA promoters
(Fig. 1B, middle panel, above) had suggested a faster migration
for HK/156 PA following cross-linking. Therefore, the
broadening of the lower band resulting from cross-linking to
the cRNA promoter again suggested a greater involvement of
the PA subunit in binding to the cRNA promoter than to the
vRNA promoter.
Direct quantitative analysis of the involvement of PB1, PB2
and PA in vRNA and cRNA promoter binding was performed by
taking advantage of the fact that with the WSN-GFP polymerase
all three polymerase subunits can be separated (Figs. 1A and B,
above). Quantitation of the non-immunoprecipitated, cross-linked
polymerase allows a more accurate determination of the
contribution of each subunit to total promoter binding because
this method is not affected by differences in antibody avidity. The
percentage contribution of the PB1, PB2 and PA subunits to total
signal for vRNA and cRNA promoter binding in Fig. 1C (lanes 4
and 9) was quantitated by phosphorimaging (Supplementary
Fig. 1). Fig. 1D shows these data expressed as a ratio of the
percentage contribution to cRNA promoter binding compared to
percentage contribution to vRNA promoter binding for each
Fig. 1. PA involvement in vRNA and cRNA promoter binding. (A) 293Tcells were transfected with WSN PB1,WSN PB2-TAP and either WSN PA (WSN, lane 2), A/
HongKong/156/97 PA (HK/156, lane 3), WSN PA-GFP (WSN-GFP, lane 4) or no PA (−PA, lane 1). Crude cell lysates were harvested after 40 h and polymerase was
partially purified using the PB2-TAP subunit. The partially purified protein was then separated by 7.5% SDS–PAGE and silver stained. The positions of the 3
polymerase subunit bands are indicated on the right. Molecular weight markers (75 and 100 kDa) are shown on the left. The PB1 band in lane 1 (−PA) is faint and is
indicated by ⁎. This band is more visible in the −PA lanes shown in Figs. 3A and 4A. (B) Partially purified polymerase containingWSN PB1 and PB2-TAP with either
WSN PA (WSN, top panel), HK/156 PA (HK/156, middle panel) or PA-GFP (WSN-GFP, bottom panel) in the presence of [32P]-labelled model vRNA or cRNA
promoter was exposed to UV light (254 nm) and products were immunoprecipitated with antibodies specific for PB1 (lanes 2 and 7), PB2 (lanes 3 and 8), PA (lanes 4
and 9) or no antibody (lanes 5 and 10). Products were then separated by 7.5% SDS–PAGE and detected by autoradiography. A no immunoprecipitation control (Input)
is also shown (lanes 1 and 6). The PB1 band in cRNA cross-linking (lane 6) is diffuse probably because it is a doublet as observed before (Crow et al., 2004). (C) The
same samples shown in panel B lanes 1 and 6, above, were separated side-by-side by 7.5% SDS–PAGE and detected by autoradiography. WSN-GFP+ (lanes 5 and 10)
indicates a longer exposure of lane WSN-GFP (lanes 4 and 9). (D) Quantitation of cross-linked products in WSN-GFP lanes (lanes 4 and 9) from panel C by
phosphorimaging analysis. Percentage contribution to total binding of each subunit was calculated and a ratio of binding to cRNA compared to binding to vRNAwas
performed. Means and standard deviations are shown as calculated from 3 independent experiments.
196 H.J. Maier et al. / Virology 370 (2008) 194–204polymerase subunit. In the case of PB2, there is little change in
binding to either the vRNA or cRNA promoter, with a mean ratio
of 1.00. In the case of PB1, the reduced binding to the cRNA
promoter observed in Fig. 1B gives a ratio of 0.80. Notably,
however, for PA there is a 2.5-fold increase in binding to the
cRNA promoter compared to binding to the vRNA promoter. In
summary, these data suggested a differential requirement for the
three polymerase subunits in binding to the vRNA and cRNApromoters— specifically, the PB1 subunit is required to a greater
extent in binding to the vRNA promoter and the PA subunit is
required to a greater extent in binding to the cRNA promoter.
Selection of amino acids in PA for alanine scanning mutation
As PB1 binding to the vRNA promoter has been well studied
(Gonzalez and Ortin, 1999; Jung and Brownlee, 2006; Li et al.,
Fig. 3. Effect of PA mutations on assembly of the heterotrimeric polymerase
complex and expression levels of PA. (A) 293T cells were transfected with PB1,
PB2-TAP and wild type (WT), mutant or no PA (−PA). Crude cell lysates were
harvested after 40 h and polymerase was partially purified using the PB2-TAP
subunit. The partially purified protein was then separated by 7.5% SDS–PAGE
and silver stained. The positions of the 3 polymerase subunit bands are indicated
on the right. Molecular weight markers (75 and 100 kDa) are shown on the left.
An asterisk indicates α and β Hsp90 as previously identified by LC-MS/MS
(Deng et al., 2005). (B) 293T cells were transfected with wild type (WT) or
mutant PA alone or no PA (−PA). Crude cell lysates were harvested after 24 h
and analysed byWestern blot using an anti-PA antibody (kind gift from T. Deng,
University of Oxford). The position of the PA band is indicated to the right.
Underlining denotes polymerases that have been grouped (see text).
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to the cRNA promoter by expanding a previous mutagenesis
study of PA (Hara et al., 2006). In this previous study,
polymerase containing mutations R170A and L175A in the PA
subunit showed a severe reduction in transcription and
replication activity in an in vivo reconstitution of RNP followed
by primer extension (Hara et al., 2006). This suggested that the
R170–L175 region may have an important function in
controlling the activity of the polymerase complex and may be
involved in promoter binding. Mutagenesis of this region was
extended here to include L163–I178. Fig. 2 shows an alignment
of the region of PA between residues 162 and 180 of typical
influenza A, B and C viruses and Thogoto virus. In this region,
L175 is the only completely evolutionary conserved residue.
Other positions were conserved between 2 and more virus types
(alignment position 163–168, 170–174, 177 and 178). To
expand the study of the 170–175 region, all residues between
R170 and L175 were selected for alanine scanning mutation,
despite their varying degrees of conservation. Towards the C-
terminus F176 was included as this aromatic residue is
conserved in influenza A viruses. We also mutated I178 due to
the conservation of hydrophobic residues at this position in
influenza A, B and C viruses and Thogoto virus. Towards the N-
terminus, we included L163, due to the conservation of this
residue in 3 virus types.We also included D164, E165, E166 and
R168 due to the conservation of charge observed at each of these
positions in either 3 virus types (D164, E166 and R168) or 2
virus types (E165) and because an E165, E166 double mutant
has previously been shown to reduce polymerase activity and be
unable to support rescue of virus (Regan et al., 2006).
Importantly, an alignment of the PA sequences from 46 influenza
A viruses, including A/HongKong/156/97, with differing HA
and NA subtypes isolated from both avian and mammalian
species, demonstrated that all the selected residues between
L163 and I178 were completely conserved. This suggests that
this sequence is important for the function of PA in influenza A
viruses. The remaining positions were not selected for muta-
genesis due to poor conservation or lack of charge conservation.
To summarise, a total of 11 alanine scanning mutants between
positions 163 and 178 were selected (Fig. 2, arrowed).Fig. 2. Alignment of residues 162 to 180 of the PA subunits of the RNA
polymerase of typical influenza A, B, C and Thogoto viruses. Accession
numbers are X17336 for influenza A/WSN/33, AF102022 for B/Victoria/2/87,
M28062 for C/JJ/50 and AF006073 for Thogoto virus. Positions selected for
alanine scanning mutation are arrowed. Mutants R170A and L175A from a
previous study (Hara et al., 2006) are indicated with an asterisk. Numbers and
dots indicate amino acid position in the A/WSN/33 sequence. Alignment with
ClustalW using default parameters. Dark shading indicates complete evolution-
ary conservation between the influenza A, B, C and Thogoto virus sequences.
Pale shading indicates partial evolutionary conservation between the influenza
A, B, C and Thogoto virus sequences.Heterotrimeric complex formation by polymerases with mutant
PA subunits
Since failure to correctly assemble the heterotrimeric poly-
merase complex would result in a lack of polymerase activity, the
mutants were initially examined for heterotrimeric complex
formation. Polymerases containing wild type or mutant PAwere
partially purified using a C-terminally TAP-tagged PB2 subunit
(see Materials and methods) from 293T cells transiently
expressing the 3 polymerase subunits. Assembly of the complex
was then assayed by 7.5% SDS–PAGE followed by silver
staining (Fig. 3A). The PA band was clearly present in one group
ofmutants (D164A, E165A, E166A,R170A,K172A, T173A and
F176A, Fig. 3A, underlined), although the level was slightly
reduced for mutants D164A and K172A. However, for a second
group of mutants (L163A, R168A, I171A, R174A, L175A and
I178A, Fig. 3A, no underline) the PA band was present in
suboptimal amounts (b25%, estimated visually). We hypothe-
sised that the reduction in complex formation by the second group
of mutants was due to poor expression of these mutants PAs. To
confirm this hypothesis, the mutant PAs were expressed in 293T
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analysed by Western blotting. Fig. 3B shows that lower amounts
(b25%, estimated visually) of PA were present for the second
group of mutants (Fig. 3B, no underline) compared to the first
group (Fig. 3B, underlined), although mutant D164A had levels
reduced to around 75% and mutant K172A had levels reduced to
around 25–50%, estimated visually. This confirmed our hypoth-
esis and suggested that PAs from the second group of mutants
may be less stable, as observed previously for other N-terminal
PA mutants (Hara et al., 2006). As a result of this observation,
mutants from the second group were not pursued further. Seven
mutants, D164A, E165A, E166A, R170A, K172A, T173A and
F176A, however, were selected because these mutant PAs
were capable of polymerase complex formation.Fig. 4. Effect of selected PA mutations on in vitro transcription activity. (A) Partially
give comparable levels of PA. The partially purified protein was then separated by 7
bands are indicated on the right. Molecular weight markers (75 and 100 kDa) are sho
LC-MS/MS (Deng et al., 2005). (B) Transcription activity of partially purified polyme
mutant PA or no PA (−PA) primed with globin mRNA. The transcription products (T
products by phosphorimaging analysis. Quantitation data are expressed as a percenta
least four independent sets of data. P-values derived from one sample Student's t teIn vitro transcription activity by the selected mutant polymerases
To further characterise the 7 selected PA mutants (D164A,
E165A, E166A, R170A, K172A, T173A and F176A), poly-
merases containing wild type or mutant PAs were partially
purified on IgG-sepharose using the PB2-TAP subunit. After
quantitation of the yield of protein (see Materials and methods),
polymerase preparations were adjusted to give similar levels of
PA (Fig. 4A). They were then assayed in vitro for their
transcription activity primed by globin mRNA in the presence
of a model vRNA promoter (see Materials and methods). Two
transcription products were identified (approximately 25–30
nucleotides in length, Fig. 4B, TP1 and TP2) probably derived
from α-globin and β-globin mRNA, respectively. However, wepurified polymerase was adjusted with untransfected TAP-purified cell extract to
.5% SDS–PAGE and silver stained. The positions of the 3 polymerase subunit
wn on the left. An asterisk indicates α and β Hsp90 as previously identified by
rase, in the presence of a model vRNA promoter, containing wild type PA (WT),
P1 and TP2) are arrowed (see text). (C) Quantitation of the arrowed transcription
ge of wild type activity (with standard deviations). Quantitation was based on at
sts.
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termination, altered endonuclease cleavage or altered priming
positions. Transcriptional activity was determined by quantita-
tion of the two products arrowed (Figs. 4B and C). The activity
of 4 of the mutants (D164A, E165A, R170A and K172A) was
not significantly different from wild type in one sample
Student's t tests (Fig. 4C). The remaining 3 mutants (E166A,
T173A and F176A) showed a significant reduction in activity to
approximately 60% of wild type.
In vitro replication activity by the selected mutant polymerases
To examine the effect of the 7 selectedmutants on replication,
partially purified polymerases, adjusted to comparable levels of
PA (see Materials and methods and Fig. 4A), containing wild
type or mutant PAs were analysed in a recently developed in
vitro dinucleotide initiation of replication assay (see Materials
andmethods) (Deng et al., 2006a,b). In the presence of themodel
vRNA promoter, mutants showed levels of activity not sig-
nificantly different from wild type with the exception of E166A
which was reduced to 65% of wild type activity (significant to
pb0.01 as calculated by one sample Student's t test, Figs. 5A
and C). Surprisingly, in the presence of the cRNA promoter,
mutants D164A, E165A, E166A, T173A and F176A showed
activity reduced to 20% of wild type activity or less (significant
to pb0.01 as calculated by one sample Student's t test, Figs. 5B
and D). The remaining two mutants, R170A and K172A,Fig. 5. Effect of selected PAmutations on in vitro initiation of replication. Initiation of
or no PA in the presence of a model (A) vRNA or (B) cRNA promoter using adenos
deviations of panel A by phosphorimaging analysis. Data are expressed as a percenta
phosphorimaging analysis. Data are expressed as a percentage of wild type activity. Q
one sample Student's t tests.showed levels of activity not significantly different from wild
type or only marginally reduced to 71% of wild type, respec-
tively (significant to p=0.02 as calculated by one sample
Student's t test). In summary, these results suggested that mutant
polymerases D164A, E165A, E166A, T173A and F176A have
significantly reduced initiation of replication activity in the
presence of the cRNA promoter whilst there is little or no
reduction in activity in the presence of the vRNA promoter.
Binding of polymerases containing D164A, E165A, E166A,
T173A and F176A mutant PAs to the vRNA and cRNA promoters
Since five of the mutant polymerases (D164A, E165A,
E166A, T173A and F176A) showed a marked reduction in the
initiation of replication activity in the presence of the cRNA
promoter compared to the vRNA promoter (Fig. 5), we
hypothesised that there may be a reduction in binding by these
mutants to the cRNA promoter compared to the vRNA promoter.
To test this, vRNA and cRNA promoter binding was assayed by
UV cross-linking (see Materials and methods) using the seven
selected, partially purified, quantitatively adjusted polymerases
(see Materials and methods and Fig. 4A). Figs. 6A and C show
that the mutant polymerases have vRNA binding activity not
significantly different fromwild type or only marginally reduced
to 70% and 78% of wild type binding for mutants T173A and
E166A, respectively (although this marginal reduction was
significant to p=0.05 and 0.02, respectively). Notably, however,replication activity of partially purified polymerase containing wild type, mutant
ine. The ApG products are indicated on the right. (C) Quantitation and standard
ge of wild type activity. (D) Quantitation and standard deviations of panel B by
uantitation based on at least four independent sets of data. P-values derived from
Fig. 6. Effect of PA mutations on binding to the model vRNA and cRNA promoters. Partially purified polymerase containing wild type PA (WT), mutant PA or no PA
(−PA) in the presence of (A) [32P]-labelled model vRNA promoter or (B) [32P]-labelled model cRNA promoter was exposed to UV light (254 nm) and analysed by
7.5% SDS–PAGE. Bands were detected by phosphorimaging. Positions of the cross-linked products are indicated on the right. (C) Quantitation and standard
deviations of bands in panel A expressed as a percentage of wild type binding. (D) Quantitation and standard deviations of bands in panel B expressed as a percentage
of wild type binding. The PB1 and PB2-TAP and PA bands were quantitated together to determine total promoter binding by the polymerase complex. Quantitation
based on at least four independent sets of data. P-values derived from one sample Student's t tests.
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mutants (D164A, E165A, E166A, T173A and F176A) were
significantly reduced in binding compared to wild type showing
25–60% of wild type binding activity (Figs. 6B and D). The
differences observed for these 5 mutants were significant in one
sample Student's t tests to p≤0.02 (Fig. 6D). By contrast, two
mutants, R170A and K172A, showed no significant reduction in
binding to the cRNA model promoter compared to wild type.
Overall, our results suggested that five mutant polymerases,
D164A, E165A, E166A, T173A and F176A, were inhibited in
their binding to the cRNA promoter but that there was,
quantitatively, only a small or no reduction in binding to the
vRNA promoter.
Effect of PA mutations on transcription and replication by the
polymerase in vivo
To test the effect of the mutant PA subunits on the activity of
the polymerase complex in vivo, we carried out a reconstitution
of RNP with a CAT reporter in 293T cells followed by a primer
extension assay to examine the steady-state levels of mRNA,
vRNA and cRNA, as before (see Materials and methods) (Hara
et al., 2006). Polymerase containing the five mutants, D164A,
E165A, E166A, T173A and F176A, showed markedly reduced
levels of vRNA and mRNA compared to wild type and no
detectable cRNA (Figs. 7A and B), consistent with theseresidues being important for transcription and/or replication.
Unexpectedly, however, polymerase containing mutants R170A
and K172A also showed a considerable reduction in activity
(see Discussion).
Discussion
In this study we have shown that the PA subunit of the
influenza A virus polymerase complex contributes more to
binding to a model cRNA promoter and the PB1 subunit con-
tributes more to binding to a model vRNA promoter (Fig. 1).
Promoter binding by the PB1 subunit has been studied previ-
ously and was not followed up further (Gonzalez and Ortin,
1999; Jung and Brownlee, 2006; Li et al., 1998). It would be
interesting, however, to investigate the cRNA binding properties
of previously identified vRNA promoter binding mutants in the
PB1 subunit (Jung and Brownlee, 2006; Li et al., 1998).
Since the importance of PA in promoter binding has not
previously been emphasised, we carried out a mutagenesis
study of a region of PA to try and identify residues involved in
binding of PA to the cRNA promoter. Extensive mutagenesis of
the N and C-termini of PA (Fodor et al., 2002; Hara et al., 2006)
suggested that the region 170–175 may have an important
function. Eleven alanine scanning mutants were constructed at
evolutionary conserved or partially conserved residues between
residues L163 and I178 (Fig. 2). Six mutations (L163A, R168A,
Fig. 7. In vivo RNA synthesis by influenza A virus polymerase RNP complex
containing selected mutant PA subunits. 293T cells were transfected with
plasmids encoding PB1, PB2, NP and a CAT reporter gene and either wild type
PA (WT), mutant PA or no PA (−PA). (A) RNA was harvested after 24 h and
levels of vRNA, mRNA, cRNA and 5S rRNA were measured by primer
extension. Positions of RNA signals are indicated by arrows on the right and
sizes in nucleotides are indicated on the left. (B) Quantitation of vRNA (closed
bars), mRNA (striped bars) and cRNA (open bars) is shown. Data have been
normalised for total RNA using the 5S rRNA signal. Data are expressed as a
percentage of wild type activity (with standard deviation). Quantitation was
based on at least three independent sets of data.
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trimeric complex formation (Fig. 3A) and, furthermore, ex-
pressed reduced levels of PA alone (Fig. 3B), potentially similar
to previously characterised PA mutants known to be targeted to
the proteasomal degradation pathway (Hara et al., 2006). These
6 mutants were not characterised further. Instead we focussed
on the remaining 7 mutants (D164A, E165A, E166A, R170A,
K172A, T173A and F176A) that were able to assemble into the
heterotrimeric complex. Due to slight variation in expression
levels of the mutant PA proteins, preparations were adjusted
based on quantitative estimates of the PAyield on silver stained
gels to give comparable levels of PA (Fig. 4A).
To determine the effect of the selectedmutations on replication
activity, the 7 selected mutants were examined using the recently
described dinucleotide initiation of replication assay (Deng et al.,
2006a,b). Significantly, for 5 mutants (D164A, E165A, E166A,
T173A and F176A), the level of activity compared to wild type in
the presence of the cRNA model promoter was statisticallysignificantly reduced whilst there was no or only a small
quantitative reduction (for E166A) on activity in the presence of
vRNA promoter (Fig. 5). We hypothesised that these differences
in initiation activity were due to greater inhibition of mutations
D164A, E165A, E166A, T173A and F176A on binding by the
polymerases to the model cRNA compared to the vRNA
promoter. In support of this hypothesis, subsequent cross-linking
of mutant polymerases D164A, E165A, E166A, T173A and
F176A to the cRNApromoterwas reduced compared towild type,
whereas cross-linking to the vRNA promoter was not reduced or
was reduced to a lesser extent (Fig. 6). We cannot be sure whether
these residues are directly involved in cRNA promoter binding or
whether mutations at these positions alter protein conformation,
thereby indirectly affecting promoter binding. Interestingly,
however, all 5 amino acids identified here (i.e. D, E, T and F)
have been shown previously to be involved directly in other,
unrelated, protein–RNA interactions (Guallar and Borrelli, 2005;
Law et al., 2005; Peabody and Chakerian, 1999), suggesting that
these residues may be directly involved here.
When mutant polymerases were examined for in vitro
transcriptional activity, mutants E166A, T173A and F176A
were shown to have slightly reduced activity compared to wild
type (Fig. 4). For mutants E166A and T173A this observation is
entirely consistent with the slight reduction in vRNA promoter
binding observed in cross-linking experiments (Figs. 6A and
C). Mutant E166A also demonstrated reduced initiation of
replication activity in the presence of the vRNA promoter (Figs.
5A and C). However, mutant F176A did not show any reduction
in vRNA promoter binding (Figs. 6A and C). We can only
speculate that this mutation may have a small additional affect
on cap-binding or endonuclease activity untested here, thereby
slightly reducing transcriptional activity.
In this study, we have identified five point mutations in the PA
subunit that result in a strong inhibition of initiation of replication
activity in the presence of the cRNA promoter (Fig. 5). However,
the level of inhibition of polymerase binding to the cRNA
promoterwas not as great as the inhibition of replication, although
the reduction in binding was statistically significant (Fig. 6). The
difference in the extent of inhibition may be due to differences
between the assays. Thus, it is possible that a proportion of the
observed cRNA binding by the mutant polymerases in the UV
cross-linking assay is not in a fully functional conformation.
Alternatively, these mutations might have a secondary affect on
the initiation of replication by the polymerase complex, in
addition to their effect on promoter binding.
The in vitro results were confirmed by an in vivo reconstitution
of RNP assay in 293T cells (Fig. 7). This confirmed that mutants
D164A, E165A, E166A, T173A and F176A had dramatically
reduced activity in vRNA, mRNA and cRNA synthesis in vivo.
The reduction in synthesis of all three classes of RNAwould be
expected as a result of an inhibition in cRNA promoter binding,
resulting in a subsequent reduction in vRNA synthesis. In turn,
there would then be a reduction in mRNA and cRNA synthesis,
due to a lack of vRNA template. Due to the multiple rounds of
RNA synthesis in the in vivo assay, this effect is amplified (Jung
and Brownlee, 2006). Mutants R170A and K172A, however,
which appeared to have near wild type levels of activity in all in
202 H.J. Maier et al. / Virology 370 (2008) 194–204vitro assays (Figs. 4–6), were only weakly active in vivo (Fig. 7).
The reason for this discrepancy is unknown and possible
explanations are (i) there may be cell specific effects of these
mutations on the polymerase which contribute in vivo but were
not detected in the in vitro assays. Perhaps, for example, these
mutant PAs are transported to the nucleus less efficiently (Nieto
et al., 1994) or are unable to interact with a necessary co-factor
within the cell (Huarte et al., 2001), (ii) thesemutationsmay affect
elongation by the polymerase (Fodor et al., 2003) which would
inhibit activity in vivo but might not result in inhibition in vitro
because the in vitro assays only require extension to give a 14 or
15 nucleotide product.
In summary, we have identified an increased requirement for
PA in binding to the cRNA compared to vRNA promoter.
Furthermore, we have identified 5 point mutations in the N-
terminus of PAwhich inhibit binding to the cRNA promoter by
the polymerase complex, whereas there is no or only a minor
quantitative reduction on vRNA promoter binding. We propose
that these residues are directly or indirectly involved in cRNA
promoter binding. This study is consistent with previous reports
suggesting that there are differences in the binding strategies of
the vRNA and cRNA promoters by the polymerase complex. A
recent report showed differences in stability of the 2 promoter–
polymerase complexes (Dalton et al., 2006) and an earlier report
(Gonzalez and Ortin, 1999) concluded that there were discrete
but overlapping binding sites for the vRNA and cRNA
promoters in the PB1 subunit. Our results are also consistent
with a recently proposed model for different de novo initiation
of replication mechanisms on the 2 promoters (Deng et al.,
2006b). This model requires that the polymerase would have
different binding strategies for the two promoters to allow
initiation to occur at different positions on the template. Our
present study, however, does not allow us to determine whether
the polymerase complex has one binding pocket for both
promoters or whether there are separate binding pockets.
It is interesting that in this studywe have highlighted a function
for PA in the replication activity of the polymerase complex.
Classical reports describing temperature sensitive mutants of the
PA protein from fowl plague virus (Mahy et al., 1981; Markushin
and Ghendon, 1984) and human influenza viruses (Krug et al.,
1975; Thierry and Danos, 1982) suggested a role for PA in
replication, particularly at the level of vRNA synthesis. The data
presented here may go some way to suggest a mechanism for the
observed reduction in vRNA synthesis by polymerases contain-
ing these temperature sensitive PA subunits. It would be
interesting to analyse polymerases containing these and other
temperature sensitive PA mutants in the assays described here.
Materials and methods
Plasmids
Plasmids pcDNA-PB1, pcDNA-PB2, pcDNA-PA, pcDNA-
NP, pcDNA-PB2-TAP and pcDNA-PA-GFP for protein ex-
pression have been described previously (Deng et al., 2005;
Fodor et al., 2002; Fodor and Smith, 2004). To construct the
pcDNA-PA-HK/156 plasmid, RT-PCR was performed usingspecific primers and RNA extracted from virus as a template.
The PCR fragment was then inserted into pCR2.1-TOPO
(Invitrogen) by TA cloning. The open reading frame was
subcloned into pcDNA3A (Fodor et al., 2002) using KpnI and
NotI restriction sites. The A/HongKong/156/97 PA used here
has a single A22G silent mutation compared to the sequence of
accession number AF046095. The pPOLI-vCAT plasmid for
expression of the CAT reporter gene has also been described
previously (Fodor et al., 2002; Pleschka et al., 1996). Point
mutations in the PA gene were made by site directed muta-
genesis and were confirmed by full sequencing of the gene.
Primer sequences are available upon request.
Preparation of partially purified TAP-tagged polymerase
293T cells were transfected with the pcDNA-PB1, pcDNA-
PB2-TAP and wild type or mutant pcDNA-PA. Crude cell lysates
were harvested 40 h post-transfection and the polymerase was
partially purified by the tandem affinity purification (TAP)
method described previously (Deng et al., 2005). The partially
purified polymerase was analysed by 7.5% SDS–PAGE followed
by silver stain with Proteosilver (Sigma). Following an initial
silver stain, partially purified polymerase preparations were
adjusted with untransfected TAP-purified cell extract so that the
level of PA present was comparable (±10%). Adjustments were
made from the results of digital photography of transmitted signal
of an initial silver stained gel followed by quantitative measure-
ments of the PA image intensity using AIDA software (Raytest
GmbH, Supplementary Fig. 2). PAwas selected for normalisation
because purification was performed using a TAP-tagged PB2
subunit and PA, therefore, indicates the level of trimeric
polymerase. Following normalisation, it can be seen that there
appears to bemore PB1 and PB2-TAP present formutants D164A
and K172A (Fig. 4A). As these twomutations resulted in a partial
reduction in PA expression (Fig. 3B), it is likely that the ratio of
the three polymerase bands was altered because PB1, PB2-TAP
dimers and PB2-TAP monomers were also purified from the cell
extract. The presence of the PB2-TAP monomers and PB1, PB2-
TAP dimers is unlikely, however, to alter the activity of the
trimeric polymerase complex as these complexes show no activity
in all assays used (−PA lane, Figs. 4–6).
Crude cell lysates were analysed by 7.5% SDS–PAGE
followed by Western blotting using a rabbit anti-PA antibody, as
described previously (Engelhardt et al., 2005).
UV cross-linking assay and immunoprecipitation of cross-linked
products
UV cross-linking was performed as described previously
(Fodor et al., 2002; Hara et al., 2006). Briefly, 5 μl of
quantitatively adjusted (see Preparation of partially purified
TAP-tagged polymerase above) partially purified polymerase in
the presence of approximately 0.5 pmol (100,000 dpm) [γ32P]-
labelled 3′ end of the vRNA promoter (5′ GGCCUG-
CUUUUGCU 3′) (Dharmacon) and 4 pmol of unlabelled 5′
end of the vRNA promoter (5′ AGUAGAAACAGGCC 3′)
(Dharmacon) in a 10 μl reaction containing 10 mM HEPES (pH
203H.J. Maier et al. / Virology 370 (2008) 194–2047.5), 100 mM KCl, 2 mM MgCl2, 0.5 mM EGTA, 1 mM DTT,
10% glycerol and 8 U RNasin (Promega) was incubated at 30 °C
for 30 min. Reactions were then UV irradiated (254 nm) and
products separated by 7.5% SDS–PAGE. UV cross-linking was
also carried out with the cRNA promoter by replacing the [γ32P]-
labelled 3′ end of the vRNA promoter with approximately
0.5 pmol (100,000 dpm) [γ32P]-labelled 3′ end of the cRNA
promoter (5′ GGCCUUGUUUCUACU 3′) (Dharmacon) and
replacing the unlabelled 5′ end of the vRNA promoter with
4 pmol of the unlabelled 5′ end of the cRNA promoter (5′
AGCAAAAGCAGGCC 3′) (Dharmacon). Products were
detected by autoradiography and quantitated by phosphorima-
ging. For UV cross-linking reactions carried out with polymerase
containing HK/156 PA, polymerase preparations were diluted 1/2
or 1/4 with TAP purified untransfected cell extract in the presence
of vRNA and cRNA model promoters, respectively. These
dilutions were made due to an increase in activity of polymerase
containing the HK/156 PA (Kashiwagi and Brownlee,
unpublished).
For immunoprecipitation, following UV irradiation, protein
was denatured with 1% SDS and then incubated for 16 h at 4 °C
with 5 μl antibody specific for PB2 (Carr et al., 2006) or PA
(Engelhardt et al., 2005), 25 μl antibody specific for PB1 (Santa
Cruz) or no antibody in a 936 μl reaction containing 10 mM
HEPES (pH 8.0), 100 mM NaCl, 2 mM EDTA, 1% Igepal,
0.5% sodium deoxycholate, complete EDTA-free protease
inhibitor cocktail (Roche) and 40 U RNasin. Following
incubation with the antibody, 40 μl protein A sepharose beads
(GE Healthcare) were added and samples incubated for 1 h at
4 °C. The beads were washed twice with 10 mM HEPES (pH
8.0), 50 mM NaCl, 1% Triton X-100, 5 mM MgCl2, 0.5%
sodium deoxycholate and 0.1% SDS. Immunoprecipitated
proteins were released by boiling at 95 °C for 5 min. Proteins
were separated by 7.5% SDS–PAGE and bands visualised by
autoradiography.
In vitro transcription assay
The quantitatively adjusted (see Preparation of partially
purified TAP-tagged polymerase above), partially purified,
polymerases were used in the globin mRNA-primed transcrip-
tion assay as described previously (Fodor et al., 2002). Briefly,
1.5 μl of TAP-purified polymerase was mixed with 50 ng globin
mRNA (Sigma), 1.75 pmol of the 5′ strand of the model vRNA
promoter, 1.75 pmol of the 3′ strand of the model vRNA
promoter, 5 mM MgCl2, 1 mM DTT, 0.15 μM [α
32P] GTP
(3000 Ci/mmol, GE Healthcare), 1 mM ATP, 0.5 mM CTP and
2 U RNasin (Promega) in a reaction volume of 3 μl. After
60 min incubation at 30 °C, transcription products were
analysed by 16% polyacrylamide gel containing 7 M urea in
Tris–Borate–EDTA (TBE) buffer. Products were detected by
autoradiography and quantitated by phosphorimaging.
In vitro replication assay
The dinucleotide initiation of replication assay was per-
formed as described previously (Deng et al., 2006a,b; Hara et al.,2006), using adenosine rather than ATP. Briefly, 1.5 μl of
quantitatively adjusted (see Preparation of partially purified
TAP-tagged polymerase above) TAP-purified polymerase was
mixed with 0.02 μM [α32P] GTP (3000 μCi/mmol), 5 mM
MgCl2, 1 mMDTT, 3 URNasin, 1mM adenosine and 1.75 pmol
each of the 5′ and 3′ strands of a model vRNA or model cRNA
promoter in a 3 μl reaction volume. Following 16 h incubation at
30 °C, the ApG product was analysed by 25% PAGE containing
6 M urea in TBE buffer. Products were detected by
autoradiography and quantitated by phosphorimaging.
RNA isolation and primer extension assay
293T cells were transfected with pcDNA-PB1, pcDNA-PB2,
wild type or mutant pcDNA-PA, pcDNA-NP and pPOLI-vCAT.
RNAwas harvested 24 h post-transfection using TRIzol reagent
(Invitrogen). RNAwas then analysed in a primer extension assay
using three primers—one for negative sense RNA (vRNA), one
for positive sense RNA (mRNA and cRNA) and one for host cell
5S rRNA as an internal control (Fodor et al., 2002; Hara
et al., 2006). Transcription products were separated by 6%
PAGE containing 7 M urea in TBE buffer and visualised by
autoradiography.
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